Miracle Mineral Supplement - MMS - Helps Relieve Chronic Pain 

Toxin Release Links

FFT-SolutionTM, Used to Assist In Oil Spill Cleanup

Mineral quashes deadly bacterial poisons

Press Release

New findings about the way cells work could lead to a test and therapy for kidney failure caused by E. coli

Thallion and LFB Complete Patient Enrollment of Phase II SHIGATEC Trial

Toxin Release News

FFT-SolutionTM, Used to Assist In Oil Spill Cleanup

NORTH CHARLESTON, S.C., Jan. 26, 2012 /PRNewswire/ -- A new green, toxin free, cost efficient Oil Dispersant has been used to assist in the Oil Spill Remediation at a mid-Atlantic naval facility. FFT-SolutionTM ...

Read more...

---

Mineral quashes deadly bacterial poisons

In animals, manganese shows promise fighting a hemorrhagic E. coli toxin

Read more...

---

Press Release

GlobalData estimates that the global dystonia therapeutics market was valued at $606m in 2010 and is expected to grow to $1.02 billion with a projected Compound Annual Growth Rate (CAGR) of 6.7%. Such steady growth in the dystonia therapeutics market is primarily attributed to an increase in the prescription population for botulinum toxin (Botox).

Read more...

---

New findings about the way cells work could lead to a test and therapy for kidney failure caused by E. coli

Ever since the water supply in Walkerton, Ont., was contaminated by E. coli in 2000, Dr. Philip Marsden has been trying to figure out just how a toxin released by that particular strain of the bacteria causes kidney damage in children.

Read more...

---

Thallion and LFB Complete Patient Enrollment of Phase II SHIGATEC Trial

MONTRÉAL, QUÉBEC and LES ULIS, FRANCE--(Marketwire - Jan. 9, 2012) - Thallion Pharmaceuticals Inc. (TSX:TLN) and LFB Biotechnologies announced today that they have completed patient enrollment for the high dose cohort (3 mg/kg) of the Phase II SHIGATEC trial, evaluating Shigamabs ® as a treatment for Shiga toxin-producing E. coli (STEC) infection.

Read more...

---